Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

BACKGROUND: To demonstrate the efficacy and safety of intravitreal injections of conbercept versus laser photocoagulation in the treatment of diabetic macular oedema (DME). METHODS: A 12-month multicentre, randomised, double-masked, double-sham, parallel controlled, phase III trial (Sailing Study),...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kun, Wang, Hanying, He, Wei, Ye, Jian, Song, Yanping, Wang, Yusheng, Liu, Xiaoling, Wu, Zhifeng, Chen, Shaojun, Fan, Ke, Liu, Yuling, Zhang, Feng, Li, Zhiqing, Liu, Lin, Zhang, Junjun, Zhang, Xuedong, Ye, Junjie, Liang, Xiaoling, Li, Xiaoxin, Ke, Xiao, Wu, Quan, Li, Jie, Tao, Shanshan, Wang, Xinguo, Rosenfeld, Philip, Heier, Jeffrey S, Kaiser, Peter, Xu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510409/
https://www.ncbi.nlm.nih.gov/pubmed/34001667
http://dx.doi.org/10.1136/bjophthalmol-2020-318690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510409/
https://www.ncbi.nlm.nih.gov/pubmed/34001667
http://dx.doi.org/10.1136/bjophthalmol-2020-318690

Ejemplares similares